514 related articles for article (PubMed ID: 17392272)
1. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
2. Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.
Tolg C; Hamilton SR; Nakrieko KA; Kooshesh F; Walton P; McCarthy JB; Bissell MJ; Turley EA
J Cell Biol; 2006 Dec; 175(6):1017-28. PubMed ID: 17158951
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization.
Tolg C; Liu M; Cousteils K; Telmer P; Alam K; Ma J; Mendina L; McCarthy JB; Morris VL; Turley EA
J Biol Chem; 2020 Apr; 295(16):5427-5448. PubMed ID: 32165498
[TBL] [Abstract][Full Text] [Related]
4. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells.
Pilarski LM; Pruski E; Wizniak J; Paine D; Seeberger K; Mant MJ; Brown CB; Belch AR
Blood; 1999 May; 93(9):2918-27. PubMed ID: 10216086
[TBL] [Abstract][Full Text] [Related]
5. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
[TBL] [Abstract][Full Text] [Related]
6. CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.
Grass GD; Tolliver LB; Bratoeva M; Toole BP
J Biol Chem; 2013 Sep; 288(36):26089-26104. PubMed ID: 23888049
[TBL] [Abstract][Full Text] [Related]
7. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan.
Carvalho AM; Soares da Costa D; Reis RL; Pashkuleva I
Acta Biomater; 2022 Jul; 146():187-196. PubMed ID: 35577044
[TBL] [Abstract][Full Text] [Related]
8. RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity.
Tolg C; Hamilton SR; Morningstar L; Zhang J; Zhang S; Esguerra KV; Telmer PG; Luyt LG; Harrison R; McCarthy JB; Turley EA
J Biol Chem; 2010 Aug; 285(34):26461-74. PubMed ID: 20558733
[TBL] [Abstract][Full Text] [Related]
9. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
[TBL] [Abstract][Full Text] [Related]
10. CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.
Chang G; Wang J; Zhang H; Zhang Y; Wang C; Xu H; Zhang H; Lin Y; Ma L; Li Q; Pang T
Br J Cancer; 2014 Feb; 110(4):916-27. PubMed ID: 24434427
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2.
Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
J Bone Miner Metab; 2012 May; 30(3):293-303. PubMed ID: 21947782
[TBL] [Abstract][Full Text] [Related]
12. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo SE; He Y; Daughters C; Knutson TP; Henzler CM; Price MA; Shanley R; Witschen P; Tolg C; Kaspar RE; Hallstrom C; Gittsovich L; Sulciner ML; Zhang X; Forster CL; Lange CA; Shats O; Desler M; Cowan KH; Yee D; Schwertfeger KL; Turley EA; McCarthy JB; Nelson AC
J Pathol; 2023 Jul; 260(3):289-303. PubMed ID: 37186300
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
16. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation.
Carvalho AM; Soares da Costa D; Paulo PMR; Reis RL; Pashkuleva I
Acta Biomater; 2021 Jan; 119():114-124. PubMed ID: 33091625
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronate receptors mediating glioma cell migration and proliferation.
Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
[TBL] [Abstract][Full Text] [Related]
19. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.
Shigeishi H; Higashikawa K; Takechi M
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1629-40. PubMed ID: 24676428
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation.
Gouëffic Y; Guilluy C; Guérin P; Patra P; Pacaud P; Loirand G
Cardiovasc Res; 2006 Nov; 72(2):339-48. PubMed ID: 16934786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
